Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands

Nathalie L. Albert; Matthias Preusser; Norbert Galldiks; Jana Ivanidze

doi:10.2967/jnumed.124.268314

EditorialEditorial

Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands

Nathalie L. Albert, Matthias Preusser, Norbert Galldiks and Jana Ivanidze

Journal of Nuclear Medicine January 2025, 66 (1) 24-25; DOI: https://doi.org/10.2967/jnumed.124.268314

Nathalie L. Albert

1Department of Nuclear Medicine, LMU Hospital, LMU Munich, Munich, Germany;

2German Cancer Consortium, Partner Site Munich, Munich, Germany;

3Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Preusser

4Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Norbert Galldiks

5Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany;

6Institute of Neuroscience and Medicine, Research Center Juelich, Juelich, Germany;

7Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jana Ivanidze

8Department of Radiology, Weill Cornell Medicine, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

Article Information

vol. 66 no. 1 24-25

DOI

https://doi.org/10.2967/jnumed.124.268314

PubMed

39389626

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication June 26, 2024
Accepted for publication September 9, 2024
Published online January 3, 2025.

Article Versions

previous version (October 10, 2024 - 08:33).
You are viewing the most recent version of this article.

Author Information

Statistics from Altmetric.com

Cited By...

Citations
Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage:

No statistics are available.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 1

January 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands

Nathalie L. Albert, Matthias Preusser, Norbert Galldiks, Jana Ivanidze

Journal of Nuclear Medicine Jan 2025, 66 (1) 24-25; DOI: 10.2967/jnumed.124.268314

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands

Nathalie L. Albert, Matthias Preusser, Norbert Galldiks, Jana Ivanidze

Journal of Nuclear Medicine Jan 2025, 66 (1) 24-25; DOI: 10.2967/jnumed.124.268314

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands

Article Information

Article Versions

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage:

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles